Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC) | MicrobiomeTrials← Back to trialsNCT05987852
Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2024-01-09Est. Completion: 2027-09-01
Enrollment target: 126 participants Locations- University of Alabama Medicine, Birmingham, Alabama, United States
- University of Los Angeles Health, Los Angeles, California, United States
- University of Miami Health, Miami, Florida, United States
- Orlando Health, Orlando, Florida, United States
- Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States
- University of Louisville, Louisville, Kentucky, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States
- Cornell University Medical Center, New York, New York, United States
- State University of New York Upstate Medical University, Syracuse, New York, United States
- Allegheny Health, Pittsburgh, Pennsylvania, United States
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Other microbiome trials you might be interested in
Inflammatory Bowel Diseases (IBD)Crohn DiseaseColitis, Ulcerative
Difficult-to-treat inflammatory bowel disease (DTT-IBD) represents a heterogeneous group of patients with treatment-refr…
Multiple LocationsEst. completion Oct 31, 2032
Inflammatory Bowel Disease
This study evaluates oral Lactobacillus reuteri as an adjunct therapy for 2 months. Endoscopic assessments will be perfo…
Suqian, ChinaCompleted Mar 30, 2026
Recruiting
Recurrent C. Difficile (rCDI)Ulcerative Colitis (UC)Metabolic Syndrome (MetS)
The gut microbiota plays a key role in immunity and metabolism and contributes to diseases such as recurrent C. difficil…
Rome, ItalyEst. completion Jan 19, 2029